Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY 4.0Frontiers in Public Health

Inverse association between macronutrient quality index and renal cancer incidence: results from the prostate, lung, colorectal, and ovarian cancer screening trial

6 affiliations
  1. 1Department of Oncology, The First Affiliated Hospital of Jinzhou Medical University
  2. 2Department of Dermatology, Southwest Hospital, The First Affiliated Hospital of Army Medical University
  3. 3Erasmus University Medical Center
  4. 4Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Chongqing Medical University
  5. 5Department of Thoracic and Cardiovascular Surgery, Yongchuan Hospital of Chongqing Medical University
  6. 6Department of Urology, Chongqing Jiulongpo People’s Hospital

Abstract

Background: The quality of dietary macronutrients, as an integrated measure of dietary patterns, has been increasingly recognized for its potential role in cancer prevention. However, prospective evidence regarding its association with renal cancer incidence and mortality remains limited. We conducted a large-scale prospective cohort study using data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial to investigate the relationships between the macronutrient quality index (MQI) and renal cancer risk and survival.

Methods: A total of 101,755 participants aged 55–74 years from 10 U.S. screening centers were included. The MQI was derived from a validated dietary history questionnaire, reflecting overall macronutrient quality. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between MQI and renal cancer incidence, with renal cancer mortality as a secondary endpoint. Sensitivity and subgroup analyses were performed to ensure robustness.

Results: Over a mean follow-up of 8.82 ± 1.95 years (897,809 person-years), 446 incident renal cancer cases were documented. In the fully adjusted model, participants in the highest MQI quartile had a significantly lower risk of renal cancer incidence compared with the lowest quartile (HR Q4 vs. Q1: 0.72; 95% CI: 0.54–0.96; P-trend = 0.032). Sensitivity and subgroup analyses confirmed the robustness of this inverse association. For renal cancer mortality (113 deaths), the association did not reach statistical significance (HR Q4 vs. Q1: 0.70; 95% CI: 0.38–1.29; P-trend = 0.422).

Conclusion: A higher macronutrient quality index is associated with a reduced risk of renal cancer in U.S. middle-aged and older adults (predominantly White participants of the PLCO trial). However, the association with renal cancer mortality was not statistically significant, which may be attributable to the limited number of fatal events and the resulting low statistical power. Further investigation in larger cohorts is warranted.

Related

  1. Incidence and prevention of postprocedural bacteraemia and complications following water vapour therapy of the prostate: a retrospective review and quality improvement initiative at a tertiary care centre
    Elias Tannous, Waleed Hassan, Jeffrey Chapman +6
    Infection prevention in practicePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Screening for prostate cancer
    CaPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  3. The PROSA and cons of prostate cancer screening.
    Rory L Cochran, Mukesh G Harisinghani
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  4. The Changing Global Epidemiology of Early-Onset Colorectal Cancer: Incidence Trends, Modifiable Risk Factors, and Future Burden Projections
    Kacper Wrzosek, Agata Koba, Pola Bakalczuk +7
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  5. Toward Precision Colorectal Cancer Screening: Integrating Clinical Risk Stratification, Molecular Biomarkers, and Artificial Intelligence
    Sorinel Lunca, Stefan Morarasu, Gabriel Mihail Dimofte
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{zhou2026inverse,
  title = {{Inverse association between macronutrient quality index and renal cancer incidence: results from the prostate, lung, colorectal, and ovarian cancer screening trial}},
  author = {Lulu Zhou and Shouguang Xie and Yuxiang Luo and Linglong Peng and Dazhan Feng and Jingluo Peng},
  journal = {Frontiers in Public Health},
  year = {2026},
  month = nov,
  doi = {10.3389/fpubh.2026.2000980},
  url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.2000980/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Inverse association between macronutrient quality index and renal cancer incidence: results from the prostate, lung, colorectal, and ovarian cancer screening trial
AU  - Lulu Zhou
AU  - Shouguang Xie
AU  - Yuxiang Luo
AU  - Linglong Peng
AU  - Dazhan Feng
AU  - Jingluo Peng
PY  - 2026
DA  - 2026/11/16
JO  - Frontiers in Public Health
DO  - 10.3389/fpubh.2026.2000980
UR  - https://www.frontiersin.org/articles/10.3389/fpubh.2026.2000980/full
AB  - Background: The quality of dietary macronutrients, as an integrated measure of dietary patterns, has been increasingly recognized for its potential role in cancer prevention. However, prospective evidence regarding its association with renal cancer incidence and mortality remains limited. We conducted a large-scale prospective cohort study using data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial to investigate the relationships between the macronutrient quality index (MQI) and renal cancer risk and survival.  Methods: A total of 101,755 participants aged 55–74 years from 10 U.S. screening centers were included. The MQI was derived from a validated dietary history questionnaire, reflecting overall macronutrient quality. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between MQI and renal cancer incidence, with renal cancer mortality as a secondary endpoint. Sensitivity and subgroup analyses were performed to ensure robustness.  Results: Over a mean follow-up of 8.82 ± 1.95 years (897,809 person-years), 446 incident renal cancer cases were documented. In the fully adjusted model, participants in the highest MQI quartile had a significantly lower risk of renal cancer incidence compared with the lowest quartile (HR Q4 vs. Q1: 0.72; 95% CI: 0.54–0.96; P-trend = 0.032). Sensitivity and subgroup analyses confirmed the robustness of this inverse association. For renal cancer mortality (113 deaths), the association did not reach statistical significance (HR Q4 vs. Q1: 0.70; 95% CI: 0.38–1.29; P-trend = 0.422).  Conclusion: A higher macronutrient quality index is associated with a reduced risk of renal cancer in U.S. middle-aged and older adults (predominantly White participants of the PLCO trial). However, the association with renal cancer mortality was not statistically significant, which may be attributable to the limited number of fatal events and the resulting low statistical power. Further investigation in larger cohorts is warranted.
SN  - 2296-2565
ER  -